These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2190142)
1. Rubella and mumps vaccines. Bakshi SS; Cooper LZ Pediatr Clin North Am; 1990 Jun; 37(3):651-68. PubMed ID: 2190142 [TBL] [Abstract][Full Text] [Related]
2. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278 [TBL] [Abstract][Full Text] [Related]
3. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251 [TBL] [Abstract][Full Text] [Related]
4. Measles, mumps, and rubella vaccines. Wharton M; Cochi SL; Williams WW Infect Dis Clin North Am; 1990 Mar; 4(1):47-73. PubMed ID: 2407778 [TBL] [Abstract][Full Text] [Related]
5. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines. Heath TC; Burgess MA; O'Brien ED Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551 [No Abstract] [Full Text] [Related]
6. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [TBL] [Abstract][Full Text] [Related]
7. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. Ljungman P; Fridell E; Lönnqvist B; Bolme P; Böttiger M; Gahrton G; Linde A; Ringdén O; Wahren B J Infect Dis; 1989 Apr; 159(4):610-5. PubMed ID: 2647859 [TBL] [Abstract][Full Text] [Related]
9. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Tischer A; Gerike E Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536 [TBL] [Abstract][Full Text] [Related]
10. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Smorodintsev AA; Nasibov MN; Jakovleva NV Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140 [TBL] [Abstract][Full Text] [Related]
12. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. Krober MS; Stracener CE; Bass JW JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930 [TBL] [Abstract][Full Text] [Related]
13. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672 [TBL] [Abstract][Full Text] [Related]
14. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population]. Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596 [TBL] [Abstract][Full Text] [Related]
15. The measles-mumps-rubella vaccination program in Finland. Lerman SJ N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541 [No Abstract] [Full Text] [Related]
17. [Mumps epidemic in vaccinated children in West Switzerland]. Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835 [TBL] [Abstract][Full Text] [Related]
18. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases. Vaccine; 1998 May; 16(8):818-22. PubMed ID: 9627939 [TBL] [Abstract][Full Text] [Related]
19. Measles, mumps and rubella: control by vaccination. van Druten JA; de Boo T; Plantinga AD Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777 [TBL] [Abstract][Full Text] [Related]
20. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]